<?xml version='1.0' encoding='utf-8'?>
<document id="7808033"><sentence text="Solid tumor treatment workshop summary." /><sentence text="Retinoic acids exert a wide range of biological activities following binding to the cognate nuclear receptors, which has several members (RAR-alpha, beta, gamma and RXR-alpha, beta, gamma)"><entity charOffset="0-14" id="DDI-PubMed.7808033.s2.e0" text="Retinoic acids" /></sentence><sentence text=" Retinoic acids lead to several different effects on tumor cells and include cell differentiation, inhibition of cell proliferation and apoptosis"><entity charOffset="1-15" id="DDI-PubMed.7808033.s3.e0" text="Retinoic acids" /></sentence><sentence text=" The expression and abundance of each receptor type, and the distinct role of each receptor type related to biologic effect is under investigation" /><sentence text=" Similarly the mechanism(s) responsible for favorable responses in certain tumor types (skin, cervical) needs to be understood to best utilize this family of compounds, either alone or in various combinations" /><sentence text=" The significancer of drug-drug interaction in regard to their effects on pharmacokinetics, receptor modulation and regulation of cytoplasmic retinoic acid receptor binding proteins (CRABPs) should be carefully evaluated in pre-clinical and clinical trials"><entity charOffset="142-155" id="DDI-PubMed.7808033.s6.e0" text="retinoic acid" /></sentence><sentence text=" Furthermore, appropriate models to study combinations of RAs with other biological response modifiers are needed" /><sentence text="" /></document>